Table IV.
Most common serious adverse events (N=1438).
| Patients |
||
|---|---|---|
| Serious adverse event | n | % |
| Pneumonia | 117 | 8·1 |
| Pyrexia | 54 | 3·8 |
| Deep-vein thrombosis | 43 | 3·0 |
| Thrombocytopenia | 42 | 2·9 |
| Dehydration | 36 | 2·5 |
| Febrile neutropenia | 36 | 2·5 |
| Anaemia | 35 | 2·4 |
| Dyspnoea | 29 | 2·0 |